BEGIN:VCALENDAR
PRODID:-//Session events Calendar//IBA//EN
CALSCALE:GREGORIAN
VERSION:2.0
BEGIN:VEVENT
DTSTAMP:20260405T145436Z
DTSTART:20220604T074500Z
DTEND:20220604T092000Z
SUMMARY:Compulsory licensing or competition arrangements: a new way to ac
 cess medicines and vaccines?
DESCRIPTION:With the Covid-19 pandemic\, a remarkable mobilisation of res
 ources occurred: governments removed anti-trust restrictionsand provided
  capital\, pharmaceutical companies large and small collaborated and bio
 technology companies and universitiespooled knowledge. There were still 
 regulatory roadblocks and problems of scale\, but the significant scient
 ific breakthroughsand miraculous innovations have helped combat the dise
 ase. This panel will discuss how (or if) the intellectual property orcom
 petition laws of different countries helped the innovation of new medica
 l technologies related to Covid-19 and recentdiscussions and examples ar
 ound business rationales\, voluntary/compulsory licensing\, antitrust an
 d key contractual issues. Thepanel will also discuss collaborations betw
 een competitors and the panoply of contractual\, IP and competition law 
 issues.\n
LOCATION:
UID:65632e86-1997-4846-9c65-1915950cdd41
END:VEVENT
END:VCALENDAR